(Q48148951)

English

The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

author name string

Merino M

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

Cano J

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

Machado A

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

73

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

750-757

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Kynurenic acid inhibits the activation of kainic and N-methyl-D-aspartic acid-sensitive ionotropic receptors by a different mechanism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Glutamate and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Intrinsic membrane properties of neostriatal neurons can account for their low level of spontaneous activity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Opposing effects on blood pressure following the activation of metabotropic and ionotropic glutamate receptors in raphe obscurus in the anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Neuroprotective effects of adenosine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Kynurenate inhibition of cell excitation decreases stroke size and deficits

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

The non-NMDA glutamate antagonist NBQX blocks the local hippocampal toxicity of kainic acid, but not the diffuse extrahippocampal damage

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Effect of 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX) on dorsal root-, NMDA-, kainate- and quisqualate-mediated depolarization of rat motoneurones in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Calcium as sculptor and destroyer of neural circuitry

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Excitatory amino acids and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

A role for non-NMDA excitatory amino acid receptors in regulating the basal activity of rat globus pallidus neurons and their activation by the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Flip and Flop: A Cell-Specific Functional Switch in Glutamate-Operated Channels of the CNS

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

MK-801 partially protects against the acute MPP+ depleting effect on dopamine levels in rat striatal slices.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

In vivo protection of striatal dopaminergic system against 1-methyl-4-phenylpyridinium neurotoxicity by phenobarbital

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Effect of kynurenate on functional deficits resulting from traumatic spinal cord injury

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0730750.X

21 January 2018

Identifiers

10.1046/J.1471-4159.1999.0730750.X

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10428073

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48148951&oldid=1457394035"